NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Rod Hicks
Peter Maccallum Cancer Centre - Melbourne / Australia
Others
AD Scientific Index ID: 4374992
-
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Rod Hicks's MOST POPULAR ARTICLES
1-)
Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working GroupSF Barrington, NG Mikhaeel, L Kostakoglu, M Meignan, M Hutchings, ...Journal of clinical oncology 32 (27), 3048-3058, 201416912014
2-)
Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in LymphomaME Juweid, S Stroobants, OS Hoekstra, FM Mottaghy, M Dietlein, ...Journal of clinical oncology 25 (5), 571-578, 200716812007
3-)
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised …MS Hofman, N Lawrentschuk, RJ Francis, C Tang, I Vela, P Thomas, ...The Lancet 395 (10231), 1208-1216, 20207972020
4-)
[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 studyMS Hofman, J Violet, RJ Hicks, J Ferdinandus, SP Thang, T Akhurst, ...The Lancet Oncology 19 (6), 825-833, 201810602018
5-)
Delivering affordable cancer care in high-income countriesR Sullivan, J Peppercorn, K Sikora, J Zalcberg, NJ Meropol, E Amir, ...The lancet oncology 12 (10), 933-980, 20118272011
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept